NLRP3 and Parkinson disease: In this study, by using P + M-induced mouse PD model, we found that CD11b-mediated NLRP3 inflammasome activation and subsequent microglial proinflammatory activation as well as oxidative damage contributed to LC/NE neurodegeneration in PD (Fig. 9).